Shuimu BioSciences

Cryo-electron microscopy (Cryo-EM), particularly Single Particle Analysis (SPA), has revolutionized structural biology by enabling the determination of high-resolution 3D structures of biological macromolecules. This powerful technique is vital for life sciences and drug development, offering insights into both the structure and functional roles of macromolecules, from single proteins to complex viruses. The journey from sample to a detailed 3D structure involves several critical stages, with the process of cryo em analysis and data processing being central to unlocking the valuable structural information contained within the raw microscope images.

Shuimu BioSciences, founded in 2017 at Tsinghua University, operates as a commercial platform offering cryo-EM structure determination services. Leveraging a strong technical heritage in structural biology, the company has established efficient, advanced workflows for both experimental procedures and data analysis. They aim to provide "One-Stop" solutions covering the entire pipeline, from gene sequences to high-resolution 3D structures.

The Single Particle Analysis (SPA) Workflow

Single Particle Analysis (SPA) integrates Cryo-EM to reveal high-resolution 3D structures. The fundamental principle involves collecting extensive 2D images of purified macromolecular particles and then using computational algorithms for processing and reconstruction to produce a detailed 3D structural model.

The comprehensive workflow for single-particle analysis typically includes several key steps:

· Project Consultation & Discussions

· Feasibility Evaluation

· Strategy Definition

· Contract & Payment

· Protein Expression & Purification

· Negative Staining (an optional preliminary step)

· Sample Freezing & Data Collection

· 2D Particle Picking

· 3D Reconstruction

· Model Refinement

· Data Delivery

While initial steps involve sample preparation and data acquisition, the subsequent stages, encompassing 2D particle picking, 3D reconstruction, and model refinement, constitute the core of the cryo em analysis and data processing workflow.

Data Collection: Capturing the Molecular World

The process begins with sample preparation, including potential preliminary analysis using negative staining to assess particle homogeneity and morphology at a lower cost. For SPA, samples are rapidly frozen to preserve them in a state close to their native condition.

Data collection is performed using powerful electron microscopes. Shuimu BioSciences operates a large commercial cryo-EM platform with 300 kV instruments located in Beijing and Hangzhou, offering 24-hour instrument access for data acquisition. The company maintains a fleet of advanced electron microscopes equipped with high-performance detectors, energy filters, spherical aberration, and phase plates to ensure imaging quality. Daily maintenance and regular inspections ensure instruments are in optimal operating condition, contributing to efficient and high-quality data collection.

Despite advanced instrumentation, data collection can present challenges. Issues such as small protein molecular weight, low concentration, high background noise, air-water interface disruption, and preferential orientation can impact the quality of the raw data. Overcoming these obstacles is crucial for successful cryo em analysis.

The Core of Cryo-EM Analysis: Data Processing

Once the raw 2D images are collected, the intensive phase of data processing begins. This stage utilizes computational algorithms to extract meaningful structural information from potentially millions of individual particle images.

1. 2D Particle Picking: The first step in the computational workflow is identifying the locations of the individual macromolecular particles within the collected 2D images. This process, known as particle picking, involves distinguishing the target particles from the background noise and features. Accurate particle picking is fundamental, as the quality and quantity of picked particles directly impact the subsequent 3D reconstruction.

2. 2D Classification (often implicitly part of picking/initial analysis): While not explicitly listed as a separate step in the workflow, classifying the picked particles into groups based on their 2D projection characteristics is a common intermediate step. This helps assess the sample's heterogeneity and identify good quality particles that represent distinct views or conformations of the target molecule. Negative staining 2D analysis is also used for characterizing structures in a two-dimensional plane.

3. 3D Reconstruction: The different 2D views of the particle obtained during data collection and classification are then computationally aligned and combined to generate an initial 3D model. This is a complex computational process that requires powerful algorithms to accurately determine the relative orientation and position of each particle.

4. Model Refinement: The initial 3D model is further refined to improve its accuracy and resolution. This involves iterative processes where the model is compared against the experimental data, and adjustments are made to minimize discrepancies. Refinement can involve optimizing parameters such as particle alignment, CTF (Contrast Transfer Function) correction, and beam-induced motion correction. The goal is to produce a detailed 3D structural model at the highest possible resolution.

5. Validation and Interpretation: After refinement, the quality of the final 3D map is assessed using various metrics. The map is then used to build or fit an atomic model of the macromolecule, allowing researchers to interpret the structure in terms of its amino acid sequence, interactions, and functional mechanisms.

Overcoming Challenges in Data Processing

As mentioned earlier, challenges like high background noise, preferential orientation, and the small size or low concentration of particles can complicate cryo em analysis. Shuimu BioSciences addresses these issues through various means, including the use of advanced methodologies and proprietary tools.

One approach involves the use of GraFuture, a series of graphene support grids developed by Shuimu. Traditional grids can exacerbate problems like gas-liquid interface absorption, severe preferred orientation, high sample concentration thresholds, and significant background noise. GraFuture™ grids, including Graphene oxide (GO) and Reduced graphene oxide (RGO) versions, offer a potential solution to the preferred orientation problem and are suitable for applications involving small protein molecular weight, low concentration, strong background noise, and damage from the air-water interface. Using GraFuture™ can help overcome bottlenecks in sample preparation that directly impact the quality of the data available for subsequent processing.

The Role of AI in Cryo-EM Data Processing

Computational power and sophisticated algorithms are essential for the computationally intensive tasks in cryo em analysis. Shuimu BioSciences leverages AI algorithms and proprietary software to enhance efficiency and accuracy.

Their independently developed SMART software suite utilizes AI to streamline the cryo-EM data analysis process. This AI-driven platform reduces machine runtime and the required data volume, improving the overall efficiency of the workflow.

Furthermore, for the analysis of nanoparticles such as LNPs, liposomes, AAV, and other viral vectors, Shuimu employs NanoSMART, a self-developed AI cryo-EM system. NanoSMART can automatically identify nanoparticle features from various electron microscope images. It provides efficient and precise characterization services, allowing users to obtain detailed reports with one-click operation. The system enhances the clarity of low-quality images to optimize recognition results.

NanoSMART's capabilities extend to detailed data analysis functions. Users can obtain detailed reports covering aspects like size distribution, roundness, and layered full/empty integrity. The system provides both an overall project data summary and detailed information for individual images. The project data summary includes displays of particle size, roundness, and bilayer membrane histograms, multidimensional statistics, and tables, offering a comprehensive view of the project's statistical information. Users can switch histogram dimensions and analyze particle size distribution per image via detailed tables. This detailed and automated analysis capability significantly speeds up the characterization process and provides deeper insights into the sample's properties.

Achieving High Resolution

The ultimate goal of the cryo em analysis and data processing workflow is to achieve high-resolution 3D structures. Shuimu BioSciences emphasizes the uncompromising pursuit of resolution, using cutting-edge equipment and advanced computing platforms specifically built for high-resolution structural analysis. Their extensive experience, with over 200 completed cryo-EM projects and more than 150 structures resolved, demonstrates their capability. They have successfully elucidated protein structures as small as 51kDa and achieved resolutions as high as 1.4Å, continuously pushing the boundaries of the technology. Over 300 proteins have been resolved with exceptional resolution better than 3.5Å.

Applications Benefiting from Detailed Cryo-EM Analysis

High-resolution structural insights derived from detailed cryo em analysis are critical across numerous fields. Single-particle analysis can reveal the 3D structures of a wide range of biomacromolecules, including various types of proteins (membrane proteins, enzymes, ribosomes), DNA and RNA structures, protein-nucleic acid complexes, and viral particles like SARS-CoV-2, influenza virus, and African swine fever virus.

Furthermore, Cryo-EM plays a crucial role in the vaccine field, aiding viral structure analysis for vaccine R&D (e.g., SARS-CoV-2, Influenza, Measles), vaccine quality control by examining morphology, particle size, integrity, and aggregation, antibody-vaccine interaction studies to clarify antibody binding, and rapidly responding to viral mutations by analyzing new variants.

In antibody drug development, cryo em analysis provides high-resolution 3D structures of antibody-antigen interactions, helping understand recognition mechanisms and binding sites. It is used for mechanism of action studies, optimizing and designing antibody drugs, and analyzing the structure of membrane protein targets like GPCRs. The speed and clarity of Cryo-EM structural analysis accelerate the optimization of antibody designs and overall drug development processes.

Why Choose Shuimu BioSciences for Cryo-EM Analysis and Data Processing?

Choosing the right partner for Cryo-EM studies, especially for the critical data processing phase, is essential. Shuimu BioSciences offers several advantages:

· Cutting-Edge Equipment: Purpose-built for high-resolution structural analysis, equipped with top-tier instruments and advanced computing platforms.

· Elite Scientist Team: Composed of PhD-level experts specializing in structural biology, protein science, and computational biology, with extensive experience.

· Extensive Experience: Over 200 cryo-EM projects covering diverse samples and successful resolution of over 150 structures, demonstrating comprehensive ability.

· Uncompromising Pursuit of Resolution: Dedicated to achieving high resolution, with a best resolution of 1.4Å achieved.

· AI-Driven Platform: Independently developed AI software suites like SMART and NanoSMART streamline data analysis, reducing runtime and improving efficiency and accuracy.

· Professional Quality Service: Daily platform maintenance, experienced technicians, and support for various data analysis aspects ensure reliable service.

· One-Stop Solution: Offering integrated services from protein preparation to structure determination minimizes variability and standardizes the pipeline.

The detailed and accurate structural information derived from expert cryo em analysis and data processing is invaluable for scientific research and drug discovery. Shuimu BioSciences provides comprehensive services to support researchers through this complex workflow.

To learn more about their cryo em analysis, data processing services, and how they can support your structural biology research, please visit https://shuimubio.com/.

Contact us

See Unseeable.
Drug Undruggable.

Founded in 2017, Shuimu BioSciences aims to bring the power of cryo-EM to innovative therapeutics developers.

Contacts

1 Broadway 5th floor, Cambridge, MA 02142, United States+1 (650) 680 9383

Hi@shuimubio.com

Copyright © 2026 Shuimu Biosciences Ltd.
京ICP备2020035593号